scispace - formally typeset
Open AccessJournal ArticleDOI

Sourdough Fermentation Degrades Wheat Alpha-Amylase/Trypsin Inhibitor (ATI) and Reduces Pro-Inflammatory Activity.

Reads0
Chats0
TLDR
It is suggested that sourdough fermentation can degrade ATI structure and bioactivity, and point to strategies to improve product development for wheat sensitivity patients.
Abstract
The ingestion of gluten-containing foods can cause wheat-related disorders in up to 15% of wheat consuming populations. Besides the role of gluten, α-amylase/trypsin inhibitors (ATI) have recently been identified as inducers of an innate immune response via toll-like receptor 4 in celiac disease and non-celiac wheat sensitivity. ATI are involved in plant self-defense against insects and possibly in grain development. Notably, they are largely resistant to gastrointestinal proteases and heat, and their inflammatory activity affects not only the intestine, but also peripheral organs. The aim of this study was to understand the changes of ATI throughout the sourdough and yeast-fermented bread-making processes. ATI tetramers were isolated, fluorescein-labelled, and added to a mini-dough bread-making system. When the pH decreased below 4.0 in sourdough fermentation, the ATI tetramers were degraded due to the activation of aspartic proteases, whilst in yeast fermentation, ATI tetramers remained intact. The amylase inhibitory activity after sourdough fermentation decreased significantly, while the concentration of free thiol groups increased. The glutathione reductase activity of Fructilactobacillus sanfranciscensis did not contribute to the reduction of ATI tetramers. Compared to the unfermented wheat, sourdough fermentation was able to decrease the release of pro-inflammatory cytokines monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor alpha (TNF-α) in quantitative ATI extracts added to the human monocytic cell line THP-1. The current data suggest that sourdough fermentation can degrade ATI structure and bioactivity, and point to strategies to improve product development for wheat sensitivity patients.

read more

Citations
More filters
Journal ArticleDOI

Recent research advances of lactic acid bacteria in sourdough: origin, diversity, and function

TL;DR: Two representative LAB species, Pediococcus pentosaceus and Fructilactobacillus sanfranciscensis, are discussed with respect to their performance when used in individually or in combination with other strains for fermentation, with these strains having important function in a complex microbial community.
Journal ArticleDOI

The Complex Role of Lactic Acid Bacteria in Food Detoxification

TL;DR: In this article , a state-of-the-art review aims to summarize and discuss the data revealing the involvement of LAB in the detoxification of foods from hazardous agents of microbial and chemical nature.
Journal ArticleDOI

Bacteria do it better! Proteomics suggests the molecular basis for improved digestibility of sourdough products

TL;DR: In this paper, the authors evaluated the dynamics of proteolysis during dough fermentation started with different lactic acid bacteria species, through the identification of intermediate and small-sized peptides generated during fermentation.
Journal ArticleDOI

Intestinal Exposure to Food-Derived Protease Inhibitors: Digestion Physiology- and Gut Health-Related Effects

TL;DR: In this paper, the authors evaluated the relevance of plant-derived protease inhibitors in protein digestion in humans and discussed the potential of PIs from whole foods and as purified compounds in decreasing symptoms of bowel-related conditions.
References
More filters
Journal ArticleDOI

No Effects of Gluten in Patients With Self-Reported Non-Celiac Gluten Sensitivity After Dietary Reduction of Fermentable, Poorly Absorbed, Short-Chain Carbohydrates

TL;DR: In a placebo-controlled, cross-over rechallenge study, there is no evidence of specific or dose-dependent effects of gluten in patients with NCGS placed diets low in FODMAPs.
Journal ArticleDOI

Celiac Disease: From Pathogenesis to Novel Therapies

TL;DR: Based on the advanced understanding of the pathogenesis of celiac disease, targeted nondietary therapies have been devised, and some are already in phase 1 or 2 clinical trials.
Related Papers (5)